Crossmark

Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients

Crossref DOI link: https://doi.org/10.1186/s12920-019-0578-4

Published Online: 2019-09-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nazarov, Petr V. https://orcid.org/0000-0003-3443-0298
Wienecke-Baldacchino, Anke K.

Zinovyev, Andrei

Czerwińska, Urszula

Muller, Arnaud

Nashan, Dorothée

Dittmar, Gunnar

Azuaje, Francisco

Kreis, Stephanie
Funding

Funding for this research was provided by:

Fonds National de la Recherche Luxembourg (C17/BM/11664971/DEMICS)

Université du Luxembourg (R-AGR-0748-00)

Integrated BioBank of Luxembourg (n/a)
License Information

Text and Data Mining valid from 2019-09-18

Version of Record valid from 2019-09-18
More Information

Article History

Received: 20 March 2019

Accepted: 5 September 2019

First Online: 18 September 2019

Ethics approval and consent to participate

: All patients signed an informed written consent. Ethical approval of this study was obtained from the Comité National d’Ethique de Recherche Luxembourg (CNER-No. 201201/05) and from the German Ethik-Kommission der Albert-Ludwigs-Universität Freiburg (EK-Freiburg 196/09).

: Not applicable.

: The authors have declared no competing interests.

Document is current

Any future updates will be listed below